Ruscogenin Attenuates Cerebral Ischemia-Induced Blood-Brain Barrier Dysfunction by Suppressing TXNIP/NLRP3 Inflammasome Activation and the MAPK Pathway.
Ruscogenin, a sapogenin from Ophiopogon japonicus, has been shown to protect against ischemic injury to the brain. Researchers investigated its effects on blood-brain barrier dysfunction after stroke and found that it decreased brain damage, improved neurological function, and increased blood flow in mice. In brain cells, ruscogenin increased cell viability, decreased leakage, and modulated tight junction expression. It also inhibited the expression of inflammatory markers and decreased reactive oxygen species generation. These findings suggest that ruscogenin has potential for preventing and treating stroke.
- Cao G et al (2016).
- Int J Mol Sci.
- DOI:
- 10.3390/ijms17091418
- PubMed:
- 27589720